Pacific Biosciences of California, Inc. Second Quarter 2021 Financial Results Call

Rhea-AI Summary

Pacific Biosciences of California (NASDAQ: PACB) announced its quarterly conference call to discuss the second quarter 2021 financial results scheduled for August 3, 2021, at 4:30 pm ET. The call will be accessible via webcast on the company's investor relations website. Pacific Biosciences focuses on providing scientists with long-read sequencing technology through its innovative instruments, enhancing research in genomics and epigenomics across various fields.

Positive

• Innovative long-read sequencing technology enhances research capabilities.
• Cited in thousands of peer-reviewed publications, indicating strong scientific engagement.

Negative

• None.

News Market Reaction – PACB

+7.23%

+7.23% Session move

In the trading session that priced this news, PACB gained 7.23%, reflecting a notable positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MENLO PARK, Calif., July 19, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its second quarter 2021 financial results on Tuesday, August 3, 2021, at 4:30pm Eastern Time.

The call will be webcast and may be accessed at Pacific Biosciences’ website at: https://investor.pacificbiosciences.com/.

Date: Tuesday, August 3, 2021

Time: 4:30pm ET

Listen via Internet: https://investor.pacificbiosciences.com/

Toll-free: 888.366.7247

International: 707.287.9330

Conference ID: 6914707

Replay: https://investor.pacificbiosciences.com

About Pacific Biosciences

Pacific Biosciences of California, Inc. (NASDAQ: PACB) is empowering life scientists with highly accurate long-read sequencing. The company’s innovative instruments are based on Single Molecule, Real-Time (SMRT^®) Sequencing technology, which delivers a comprehensive view of genomes, transcriptomes, and epigenomes, enabling access to the full spectrum of genetic variation in any organism. Cited in thousands of peer-reviewed publications, PacBio^® sequencing systems are in use by scientists around the world to drive discovery in human biomedical research, plant and animal sciences, and microbiology.

Contacts

Investors:
Todd Friedman
650.521.8450
ir@pacificbiosciences.com

FAQ

What is the date and time of Pacific Biosciences' Q2 2021 earnings call?

The Q2 2021 earnings call for Pacific Biosciences is scheduled for August 3, 2021, at 4:30 pm ET.

How can I access the webcast for Pacific Biosciences' Q2 earnings call?

The webcast for Pacific Biosciences' Q2 earnings call can be accessed on their investor relations website.

What technology does Pacific Biosciences use for sequencing?

Pacific Biosciences uses Single Molecule, Real-Time (SMRT) Sequencing technology for their sequencing solutions.

What is the significance of Pacific Biosciences' sequencing technology?

The sequencing technology provides a comprehensive view of genomes, transcriptomes, and epigenomes, crucial for genetic research.